2002 Policy Safety Treatment 
Cannabis Law Report
JUNE 14, 2022
Ketamine is already registered for the treatment of depression and in 2023, the FDA might approve an MDMA assisted therapy for PTSD. However, there is a growing realization that European health systems may not be prepared for these treatments. More details: Tadeusz Hawrot, PAREA Founder and Policy Lead: tadeusz@parea.science.
Cannabis Law Report
JANUARY 21, 2022
Authority on real estate development and cultivation design, holding a commercial general contractor license since 2002. Founding member of the National Cannabis Industry Association, Lifetime Investor member of the ArcView Group, and sustaining member of Students for Sensible Drug Policy (SSDP) and Americans for Safe Access (ASA).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JANUARY 23, 2020
European Union legislation and policies "; Having regard to Regulation (EEC) no. 178/2002 of the European Parliament and of. Council of 28 January 2002, which establishes the principles and. the European Food Safety Authority and establishes procedures in the. food safety; Having regard to Regulation (EC) no.
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.
Cannabis Law Report
NOVEMBER 16, 2019
Globally, there is a never-ending cascade of information and research extolling the use of cannabis and its derivatives as a medical treatment for various illnesses and conditions. This is a public safety hazard. federal and the UK’s national banking systems. Ironically, U.S.
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).
Cannabis Law Report
JANUARY 10, 2020
Alison Felix , Senior Policy Advisor , Sam Chapman , Associate Economist , and Jordan Bass , Research Associate. v This coincided with changes in enforcement policy from the U.S. Retrieved from [link] ; Marijuana Policy Project (2019, October 19). 2019 Marijuana Policy Reform Legislation. v Warner, Joel.
Expert insights. Personalized for you.
52 
Let's personalize your content